<?xml version="1.0" encoding="UTF-8"?>
<ref id="B123-biomedicines-08-00060">
 <label>123.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hu</surname>
    <given-names>J.C.C.</given-names>
   </name>
   <name>
    <surname>Coffin</surname>
    <given-names>R.S.</given-names>
   </name>
   <name>
    <surname>Davis</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Graham</surname>
    <given-names>N.J.</given-names>
   </name>
   <name>
    <surname>Groves</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Guest</surname>
    <given-names>P.J.</given-names>
   </name>
   <name>
    <surname>Harrington</surname>
    <given-names>K.J.</given-names>
   </name>
   <name>
    <surname>James</surname>
    <given-names>N.D.</given-names>
   </name>
   <name>
    <surname>Love</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>McNeish</surname>
    <given-names>I.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor</article-title>
  <source>Clin. Cancer Res.</source>
  <year>2006</year>
  <volume>12</volume>
  <fpage>6737</fpage>
  <lpage>6747</lpage>
  <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-06-0759</pub-id>
  <pub-id pub-id-type="pmid">17121894</pub-id>
 </element-citation>
</ref>
